The mechanistic classification of addictive drugs

PLoS Medicine

Volumn 3, Issue 11, 2006, Pages 2005-2010

  Lüscher, Christian ^a   Ungless, Mark A ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; NEUROLEPTIC AGENT; BIOGENIC AMINE; CARRIER PROTEIN; DRUG; G PROTEIN COUPLED RECEPTOR; ION CHANNEL;

BRAIN REGION; CONDITIONING; DOPAMINE RELEASE; DRUG ABUSE; DRUG CLASSIFICATION; DRUG DEPENDENCE; DRUG SENSITIVITY; EUPHORIA; NONHUMAN; REVIEW; REWARD; ADDICTION; ANIMAL; CLASSIFICATION; HUMAN; METABOLISM;

ANIMALS; BIOGENIC MONOAMINES; CARRIER PROTEINS; HUMANS; ION CHANNELS; PHARMACEUTICAL PREPARATIONS; RECEPTORS, G-PROTEIN-COUPLED; SUBSTANCE-RELATED DISORDERS;

EID: 33845329490     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030437     Document Type: Review

References (61)

1. Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8: 1445-1449.
2. Pierce RC, Kumaresan V (2006) The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 30: 215-238.
3. Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28: 309-369.
4. Bechara A, Nader K, van der Kooy D (1998) A two-separate-motivational- systems hypothesis of opioid addiction. Pharmacol Biochem Behav 59: 1-17.
5. Laviolette SR, van der Kooy D (2003) Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Mol Psychiatry 8: 50-59.
6. Hnasko TS, Sotak BN, Palmiter RD (2005) Morphine reward in dopamine-deficient mice. Nature 438: 854-857.
7. Meir A, Ginsburg S, Butkevich A, Kachalsky SG, Kaiserman I, et al. (1999) Ion channels in presynaptic nerve terminals and control of transmitter release. Physiol Rev 79: 1019-1088.
8. Pickel VM, Garzon M, Mengual E (2002) Electron microscopic immunolabeling of transporters and receptors identifies transmitter-specific functional sites envisioned in Cajal's neuron. Prog Brain Res 136: 145-155.
9. Lüscher C, Jan LY, Stoffel M, Malenka RC, Nicoll RA (1997) G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron 19: 687-695.
10. Vaughan CW, Ingram SL, Connor MA, Christie MJ (1997) How opioids inhibit GABA-mediated neurotransmission. Nature 390: 611-614.
11. Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12: 483-488.
12. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, et al. (2004) Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 24: 53-62.
13. Szabo B, Siemes S, Wallmichrath I (2002) Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur J Neurosci 15: 2057-2061.
14. Snead OC 3rd, Gibson KM (2005) Gammahydroxybutyric acid. N Engl J Med 352: 2721-2732.
15. Quéva C, Bremmer-Danielsen M, Edlund A, Ekstrand AJ, Elg S, et al. (2003) Effects of GABA agonists on body temperature regulation in GABA(B(1))-/- mice. Br J Pharmacol 140: 315-322.
16. Kaupmann K, Cryan JF, Wellendroph P, Mombereau C, Sansig G, et al. (2003) Specific gamma-hydroxybutyrate-binding sites but loss of pharmacological effects of gammahydroxybutyrate in GABA(B)(1)-deficient mice. Eur J Neurosci 18: 2722-2730.
17. Cruz HG, Ivanova T, Lunn ML, Stoffel M, Slesinger PA, et al. (2004) Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system. Nat Neurosci 7: 153-159.
18. Fagen ZM, Mansvelder HD, Keath JR, McGehee DS (2003) Short- and long-term modulation of synaptic inputs to brain reward areas by nicotine. Ann N Y Acad Sci 1003: 185-195.
19. Pidoplichko VI, DeBiasi M, Williams JT, Dani JA (1997) Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390: 401-404.
20. Mansvelder HD, Keath JR, McGehee DS (2002) Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33: 905-919.
21. Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, et al. (1998) Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391: 173-177.
22. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, et al. (2005) Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436: 103-107.
23. Rice ME, Cragg SJ (2004) Nicotine amplifies reward-related dopamine signals in striatum. Nat Neurosci 7: 583-584.
24. Zhang H, Sulzer D (2004) Frequency-dependent modulation of dopamine release by nicotine. Nat Neurosci 7: 581-582.
25. Kalivas PW, Duffy P, Eberhardt H (1990) Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists. J Pharmacol Exp Ther 253: 858-866.
26. Okada H, Matsushita N, Kobayashi K, Kobayashi K (2004) Identification of GABAA receptor subunit variants in midbrain dopaminergic neurons. J Neurochem 89: 7-14.
27. Koob GF, Roberts AJ, Schulteis G, Parsons LH, Heyser CJ, et al. (1998) Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res 22: 3-9.
28. Morrow AL (1995) Regulation of GABAA receptor function and gene expression in the central nervous system. Int Rev Neurobiol 38: 1-41.
29. Kobayashi T, Ikeda K, Kojima H, Niki H, Yano R, et al. (1999) Ethanol opens G-proteinactivated inwardly rectifying K+ channels. Nat Neurosci 2: 1091-1097.
30. Lewohl JM, Wilson WR, Mayfield RD, Brozowski SJ, Morrisett RA, et al. (1999) G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action. Nat Neurosci 2: 1084-1090.
31. Appel SB, Liu Z, McElvain MA, Brodie MS (2003) Ethanol excitation of dopaminergic ventral tegmental area neurons is blocked by quinidine. J Pharmacol Exp Ther 306: 437-446.
32. Okamoto T, Harnett MT, Morikawa H (2005) Hyperpolarization-activated cation current (Ih) is an ethanol target in midbrain dopamine neurons of mice. J Neurophysiol. 95: 619-626.
33. Krystal JH, Petrakis IL, Mason G, Trevisan L, D'Souza DC (2003) N-methyl-D-aspartate glutamate receptors and alcoholism: Reward, dependence, treatment, and vulnerability. Pharmacol Ther 99: 79-94.
34. Soderpalm B, Ericson M, Olausson P, Blomqvist O, Engel JA (2000) Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res 113: 85-96.
35. Lovinger DM (1999) 5-HT3 receptors and the neural actions of alcohols: An increasingly exciting topic. Neurochem Int 35: 125-130.
36. Choi DS, Cascini MG, Mailliard W, Young H, Paredes P, et al. (2004) The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci 7: 855-861.
37. Brodie MS, Dunwiddie TV (1990) Cocaine effects in the ventral tegmental area: Evidence for an indirect dopaminergic mechanism of action. Naunyn Schmiedebergs Arch Pharmacol 342: 660-665.
38. Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, et al. (1998) Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1: 132-137.
39. Rocha BA (2003) Stimulant and reinforcing effects of cocaine in monoamine transporter knockout mice. Eur J Pharmacol 479: 107-115.
40. Chen R, Tilley MR, Wei H, Zhou F, Zhou FM, et al. (2006) Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc Natl Acad Sci U S A 103: 9333-9338.
41. Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: A review. Prog Neurobiol 75: 406-433.
42. Ingram SL, Prasad BM, Amara SG (2002) Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat Neurosci 5: 971-978.
43. Morton J (2005) Ecstasy: Pharmacology and neurotoxicity. Curr Opin Pharmacol 5: 79-86.
44. Nichols DE (2004) Hallucinogens. Pharmacol Ther 101: 131-181.
45. Aghajanian GK, Marek GJ (1999) Serotonin and hallucinogens. Neuropsychopharmacology 21: 16S-23S.
46. Goldstein A, Kalant H (1990) Drug policy: Striking the right balance. Science 249: 1513-1521.
47. Carlezon WA Jr, Wise RA (1996) Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci 16: 3112-3122.
48. Hondo H, Yonezawa Y, Nakahara T, Nakamura K, Hirano M, et al. (1994) Effect of phencyclidine on dopamine release in the rat prefrontal cortex; An in vivo microdialysis study. Brain Res 633: 337-342.
49. Ridenour TA (2005) Inhalants: Not to be taken lightly anymore. Curr Opin Psychiatry 18: 243-247.
50. Campagna JA, Miller KW, Forman SA (2003) Mechanisms of actions of inhaled anesthetics. N Engl J Med 348: 2110-2124.
51. Mennerick S, Jevtovic-Todorovic V, Todorovic SM, Shen W, Olney JW, et al. (1998) Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J Neurosci 18: 9716-9726.
52. Nagele P, Metz LB, Crowder CM (2004) Nitrous oxide (N(2)O) requires the N-methyl-D-aspartate receptor for its action in Caenorhabditis elegans. Proc Natl Acad Sci U S A 101: 8791-8796.
53. Martin JV, Iyer SV, McIlroy PJ, Iba MM (2004) Influence of oxygenated fuel additives and their metabolites on gamma-aminobutyric acidA (GABAA) receptor function in rat brain synaptoneurosomes. Toxicol Lett 147: 209-217.
54. Riegel AC, French ED (2002) Abused inhalants and central reward pathways: Electrophysiological and behavioral studies in the rat. Ann N Y Acad Sci 965: 281-291.
55. Gerasimov MR, Collier L, Ferrieri A, Alexoff D, Lee D, et al. (2003) Toluene inhalation produces a conditioned place preference in rats. Eur J Pharmacol 477: 45-52.
56. Ungless MA, Whistler JL, Malenka RC, Bonci A (2001) Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411: 583-587.
57. Saal D, Dong Y, Bonci A, Malenka RC (2003) Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37: 577-582.
58. Bellone C, Lüscher C (2006) Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nat Neurosci 9: 636-641.
59. Phillips PE, Stuber GD, Heien ML, Wightman RM, Carelli RM (2003) Subsecond dopamine release promotes cocaine seeking. Nature 422: 614-618.
60. Kalivas PW, McFarland K (2003) Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 168: 44-56.
61. Volkow ND, Li TK (2004) Drug addiction: The neurobiology of behaviour gone awry. Nat Rev Neurosci 5: 963-970.